These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29240788)

  • 1. Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy.
    Tripathi R; Sullivan R; Fan TM; Wang D; Sun Y; Reed GL; Gladysheva IP
    PLoS One; 2017; 12(12):e0189315. PubMed ID: 29240788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
    Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
    Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac-Specific Overexpression of Catalytically Inactive Corin Reduces Edema, Contractile Dysfunction, and Death in Mice with Dilated Cardiomyopathy.
    Tripathi R; Sullivan RD; Fan TM; Houng AK; Mehta RM; Reed GL; Gladysheva IP
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Low-Sodium Diet Boosts Ang (1-7) Production and NO-cGMP Bioavailability to Reduce Edema and Enhance Survival in Experimental Heart Failure.
    Tripathi R; Sullivan RD; Fan TM; Mehta RM; Gladysheva IP; Reed GL
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide affects cardiac remodeling, function, heart failure, and survival in a mouse model of dilated cardiomyopathy.
    Wang D; Gladysheva IP; Fan TH; Sullivan R; Houng AK; Reed GL
    Hypertension; 2014 Mar; 63(3):514-9. PubMed ID: 24379183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalizing Plasma Renin Activity in Experimental Dilated Cardiomyopathy: Effects on Edema, Cachexia, and Survival.
    Sullivan RD; Mehta RM; Tripathi R; Gladysheva IP; Reed GL
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31404946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure.
    Deng W; Ednie AR; Qi J; Bennett ES
    Basic Res Cardiol; 2016 Sep; 111(5):57. PubMed ID: 27506532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
    Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
    J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
    Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
    Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy.
    Gladysheva IP; Wang D; McNamee RA; Houng AK; Mohamad AA; Fan TM; Reed GL
    Hypertension; 2013 Feb; 61(2):327-32. PubMed ID: 23232642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-dependent autonomic dysregulation precedes dilated cardiomyopathy in a mouse model of muscular dystrophy.
    Sabharwal R; Weiss RM; Zimmerman K; Domenig O; Cicha MZ; Chapleau MW
    Exp Physiol; 2015 Jul; 100(7):776-95. PubMed ID: 25921929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy.
    Cooley N; Ouyang K; McMullen JR; Kiriazis H; Sheikh F; Wu W; Mu Y; Du XJ; Chen J; Woodcock EA
    Circ Heart Fail; 2013 Mar; 6(2):318-25. PubMed ID: 23258573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil Extracellular Traps in Myocardial Tissue Drive Cardiac Dysfunction and Adverse Outcomes in Patients With Heart Failure With Dilated Cardiomyopathy.
    Ichimura S; Misaka T; Ogawara R; Tomita Y; Anzai F; Sato Y; Miura S; Yokokawa T; Sato T; Oikawa M; Kobayashi A; Yoshihisa A; Takeishi Y
    Circ Heart Fail; 2024 Jun; 17(6):e011057. PubMed ID: 38847093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy in women with dilated cardiomyopathy.
    Bangi EF; Maikawa N; Kaur A; Jain R; Jain R
    Future Cardiol; 2022 Aug; 18(8):661-667. PubMed ID: 35549709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the renin-angiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy.
    Koch J; Pedersen HD; Jensen AL; Flagstad A; Poulsen K
    Res Vet Sci; 1995 Sep; 59(2):172-5. PubMed ID: 8525110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy.
    Giam B; Chu PY; Kuruppu S; Smith AI; Horlock D; Murali A; Kiriazis H; Du XJ; Kaye DM; Rajapakse NW
    Exp Physiol; 2018 Dec; 103(12):1593-1602. PubMed ID: 30311699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs.
    Tidholm A; Häggström J; Hansson K
    Am J Vet Res; 2001 Jun; 62(6):961-7. PubMed ID: 11400857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal glucose tolerance contributes to the progression of chronic heart failure in patients with dilated cardiomyopathy.
    Kim J; Nakatani S; Hashimura K; Komamura K; Kanzaki H; Asakura M; Asanuma H; Kokubo Y; Tomoike H; Kitakaze M
    Hypertens Res; 2006 Oct; 29(10):775-82. PubMed ID: 17283864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial-specific overexpression of cationic amino acid transporter-1 prevents loss of kidney function in heart failure.
    Giam B; Nomura H; Kuruppu S; Chu PY; Essid S; Kiriazis H; Du XJ; Kaye DM; Rajapakse NW
    Clin Sci (Lond); 2020 Oct; 134(20):2755-2769. PubMed ID: 33034619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.